MiR-27b-3p mimics (Fig. 9, D and E) significantly reduced mRNA and protein levels of MET, whereas miR-27b-3p inhibitor (Fig. 9, D and E) enhanced MET levels in DLBCL cells. This evidence concerns the gene MET and diffuse large B-cell lymphoma.